11 Principles in the Management of Patients with Rheumatic Disease Flashcards

1
Q

This should be the cornerstone of care for children with rheumatic disease

A

Expertise

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

First step in the care for children with rheumatic disease

A

Accurate diagnosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

T/F Team care is required for every child with a rheumatic disease

A

F, expensive and NOT required but should be available when needed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

T/F A child with a rheumatic disease should be encouraged to be as physically active as possible

A

T

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

T/F There are currently no specific evidence-based dietary recommendations for the treatment of rheumatic diseases

A

T

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Evidence-based advice for supplementation in rheumatic disease should include

A

1) Calcium + vitamin D particularly for children on GC
2) Folic acid for children on MTX
3) Supplemental iron with or w/o vitamin C for children with anemia of chronic illness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

T/F Children with rheumatic disease on chronic GC are at risk for atherosclerosis

A

T

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

T/F Children with chronic inflammatory diseases are at increased risk for dyslipidemia and CV disease

A

T

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

T/F Immunization may exacerbate or initiate rheumatic disease

A

F

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Nonlive vaccines appear to be safe in children with rheumatic disease while using GC at a dose of

A

≤2mkday

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Nonlive vaccines appear to be safe in children with rheumatic disease while using MTX at a dose of

A

≤25mkweek

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

T/F Nonlive vaccines appear to be safe in children on DMARDs and biologics

A

T

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Immunogenicity of vaccines has been shown to be appropriate despite reduced responses when on MTX at a dose of

A

> 15mkweek

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Immunogenicity of vaccines has been shown to be appropriate despite reduced responses when on GC at a dose of

A

> 2mkday

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

___ (3) have been shown to greatly reduce responses to vaccines

A

Rituximab
Cyclophosphamide
Azathioprine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

T/F TNF inhibitors have been shown to reduce immunogenicity of vaccines

A

F

17
Q

Live attenuated vaccines are recommended for children with rheumatic disease unless on

A

1) High-dose DMARDs
2) High-dose GC
3) Biological agents

18
Q

T/F Children with severe, active rheumatic disease should defer immunization until the disease is at a more stable, less active, or inactive state

A

T

19
Q

T/F Ideally, antibody level against VZV should be known before start of immunosuppressive therapy

A

T

20
Q

Varicella vaccine is generally contraindicated among patients on what medication/s

A

GC at 2mkday pred or its equivalent to a total of 20mg/day of pred or its equivalent in children who weigh >10kg taken for longer than 14 days

21
Q

This medication should NOT be used for at least 6 weeks after varicella vaccination

A

Salicylate

22
Q

Recommended for children on immunuppressives who test negative for varicella antibody

A

Immunize with varicella vaccine 3 week before starting therapy

23
Q

Recommended for children on immunoppressives exposed to varicella

A

Receive VZV Ig within 72h after exposure

24
Q

Recommended for children on immunosuppressives who develop chickenpox

A

Give oral or parenteral Acyclovir, stop immunosuppresive temporarily BUT continue GC

25
Q

Recommendation re: live vaccine for children on immunosuppressive therapy

A

Should not receive any live virus or bacterial vaccines; once immunosuppressives are stopped, live vaccines may be given after a minimum of 3 months

26
Q

Risk for opportunistic infections and varicella among children on immunosuppressives appear most commonly with use of what biologic agent

A

Anti-TNF

27
Q

Prior to initiation of anti-TNF therapy, patients should be screened for

A

Latent Tb and Hep B immunity

28
Q

The effectiveness of live vaccines may decrease if administered ___ prior to IVIg administration

A

2 weeks

29
Q

MMR and varicella vaccines should be administered ___ after IVIg

A

8 months

30
Q

If MMR and varicella are administered 14 days prior to IVIg, it is recommended that ___

A

They should be repeated 8 months after IVIg

31
Q

Transition to adult care is a process that should start when

A

When a child reaches adolescence